Armenia, Republic of vs Tunisia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Armenia, Republic of
96.0%
in 2025
Tunisia
96.0%
in 2025
Armenia, Republic of rank
26th
Tunisia rank
26th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Armenia, Republic of
- Tunisia
How they compare
Armenia, Republic of currently reports 96.0% against 96.0% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tunisia ahead.
Armenia, Republic of ranks 26th and Tunisia ranks 26th of 192 countries.
Across the 3 decades both report, Armenia, Republic of averaged higher in 1 and Tunisia in 1.
Head to head by decade
| Decade | Armenia, Republic of | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 41.6% | 0.0% | 41.6% | Armenia, Republic of |
| 2020s | 93.7% | 95.2% | 1.5% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Armenia, Republic of or Tunisia?
- Armenia, Republic of, at 96.0% against 96.0% in Tunisia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Armenia, Republic of and Tunisia?
- 0.0%, with Armenia, Republic of ahead.
- How many years of comparable data are there for Armenia, Republic of and Tunisia?
- 18 years are reported by both, from 2008 to 2025.
- How do Armenia, Republic of and Tunisia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Armenia, Republic of ranks 26th and Tunisia ranks 26th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.